Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines

(2012) Agnieszka Martowicz et al.   BMC CANCER

Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581

(2011) Donna Niedzwiecki et al.   JOURNAL OF CLINICAL ONCOLOGY

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity

(2011) H Akita et al.   ONCOGENE

Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer

(2011) Goran Benko et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis

(2010) Ranju Ralhan et al.   BMC CANCER

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

(2010) Markus M. Heiss et al.   INTERNATIONAL JOURNAL OF CANCER

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers

(2010) Ranju Ralhan et al.   PLoS One

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

(2009) M. Schmidt et al.   ANNALS OF ONCOLOGY

EpCAM: Another Surface-to-Nucleus Missile

(2009) Graham Carpenter et al.   CANCER CELL

Nuclear signalling by tumour-associated antigen EpCAM

(2009) Dorothea Maetzel et al.   NATURE CELL BIOLOGY

Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

(2008) M. Schmidt et al.   CLINICAL CANCER RESEARCH

A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers

(2008) Robert L. Camp et al.   JOURNAL OF CLINICAL ONCOLOGY